Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/xmlui/handle/11600/62314
Title: Identification of inhibitors to Trypanosoma cruzi Sirtuins based on compounds developed to human enzymes
Authors: Bastos, Tanira Matutino
Soares, Milena Botelho Pereira
Franco, Caio Haddad
Alcântara, Laura
Antonini, Lorenzo
Sabatino, Manuela
Mautone, Nicola
Freitas-Junior, Lucio Holanda
Moraes, Carolina Borsoi
Ragno, Rino
Rotili, Dante
Schenkman, Sergio [UNIFESP]
Mai, Antonello
Moretti, Nilmar Silvio [UNIFESP]
http://lattes.cnpq.br/2131472726202687
Keywords: Sirtuins
Trypanosoma cruzi
Sirtuin inhibitors
Deacetylation
Issue Date: 2020
Publisher: MDPI
Abstract: Chagas disease is an illness caused by the protozoan parasite Trypanosoma cruzi, a↵ecting more than 7 million people in the world. Benznidazole and nifurtimox are the only drugs available for treatment and in addition to causing several side e↵ects, are only satisfactory in the acute phase of the disease. Sirtuins are NAD+-dependent deacetylases involved in several biological processes, which have become drug target candidates in various disease settings. T. cruzi presents two sirtuins, one cytosolic (TcSir2rp1) and the latter mitochondrial (TcSir2rp3). Here, we characterized the e↵ects of human sirtuin inhibitors against T. cruzi sirtuins as an initial approach to develop specific parasite inhibitors. We found that, of 33 compounds tested, two inhibited TcSir2rp1 (15 and 17), while other five inhibited TcSir2rp3 (8, 12, 13, 30, and 32), indicating that specific inhibitors can be devised for each one of the enzymes. Furthermore, all inhibiting compounds prevented parasite proliferation in cultured mammalian cells. When combining the most efective inhibitors with benznidazole at least two compounds, 17 and 32, demonstrated synergistic effects. Altogether, these results support the importance of exploring T. cruzi sirtuins as drug targets and provide key elements to develop specific inhibitors for these enzymes as potential targets for Chagas disease treatment.
URI: https://repositorio.unifesp.br/xmlui/handle/11600/62314
Appears in Collections:EPM - Artigos

Files in This Item:
File Description SizeFormat 
Bastos et al 2020.pdfArtigo Completo2.98 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.